{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:21:41Z","timestamp":1788355301525,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Thammasat Postdoctoral Fellowship, Thammasat University"},{"name":"Thailand Science Research and Innovation (TSRI) Fundamental Fund, fiscal year 2024","award":["TUFF 55\/2567"],"award-info":[{"award-number":["TUFF 55\/2567"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16789-6","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:20:49Z","timestamp":1756225249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human chorion and placental mesenchymal stem cells conditioned media suppress cell migration and invasion by inhibiting the PI3K\/AKT pathway in cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Tanachapa","family":"Jantalika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirikul","family":"Manochantr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pakpoom","family":"Kheolamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangrat","family":"Tantikanlayaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Pinlaor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerachai","family":"Saijuntha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luminita","family":"Paraoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chairat","family":"Tantrawatpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"16789_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39","author":"T Kendall","year":"2019","unstructured":"Kendall, T. et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 39, 7\u201318 (2019).","journal-title":"Liver Int"},{"key":"16789_CR2","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio, A. A. et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 126, 2666\u20132678 (2020).","journal-title":"Cancer"},{"key":"16789_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio, P. et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J. Hepatol. 71, 104\u2013114 (2019).","journal-title":"J. Hepatol."},{"key":"16789_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.clinre.2020.03.024","volume":"44","author":"MM Gad","year":"2020","unstructured":"Gad, M. M. et al. Epidemiology of cholangiocarcinoma; united States incidence and mortality trends. Clin. Res. Hepatol. Gastroenterol. 44, 885\u2013893 (2020).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"16789_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-017-0542-4","volume":"19","author":"B Doherty","year":"2017","unstructured":"Doherty, B., Nambudiri, V. E. & Palmer, W. C. Update on the diagnosis and treatment of cholangiocarcinoma. Curr. Gastroenterol. Rep. 19, 1\u20138 (2017).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"16789_CR6","first-page":"198","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J. Clin. 73, 198\u2013222 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"16789_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"16789_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5009\/gnl15568","volume":"11","author":"B Blechacz","year":"2017","unstructured":"Blechacz, B. Cholangiocarcinoma: current knowledge and new developments. Gut Liver. 11, 13 (2017).","journal-title":"Gut Liver"},{"key":"16789_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00432-024-05875-3","volume":"150","author":"Z Liang","year":"2024","unstructured":"Liang, Z. et al. Targeting the PI3K\/AKT\/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression. J. Cancer Res. Clin. Oncol. 150, 342 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"16789_CR10","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","volume":"47","author":"N Jiang","year":"2020","unstructured":"Jiang, N. et al. Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior. Mol. Biol. Rep. 47, 4587\u20134629 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"16789_CR11","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1007\/s13277-013-0945-2","volume":"34","author":"S Yothaisong","year":"2013","unstructured":"Yothaisong, S. et al. Increased activation of PI3K\/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K\/mTOR Inhibition presents a possible therapeutic strategy. Tumor Biol. 34, 3637\u20133648 (2013).","journal-title":"Tumor Biol."},{"key":"16789_CR12","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.18295\/squmj.2018.18.03.002","volume":"18","author":"R Berebichez-Fridman","year":"2018","unstructured":"Berebichez-Fridman, R. & Montero-Olvera, P. R. Sources and clinical applications of mesenchymal stem cells: State-of-the-art review. Sultan Qaboos Univ. Med. J. 18, e264\u2013e277 (2018).","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"16789_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01208-w","volume":"14","author":"T Lan","year":"2021","unstructured":"Lan, T., Luo, M. & Wei, X. Mesenchymal stem\/stromal cells in cancer therapy. J. Hematol. Oncol. 14, 1\u201316 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"16789_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","volume":"60","author":"M Timaner","year":"2020","unstructured":"Timaner, M., Tsai, K. K. & Shaked, Y. The multifaceted role of mesenchymal stem cells in cancer. Semin. Cancer Biol. 60, 225\u2013237 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"16789_CR15","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1111\/jcmm.17933","volume":"27","author":"T Wu","year":"2023","unstructured":"Wu, T. et al. Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non\u2010small\u2010cell lung cancer: microRNA\u201030b\u20105p, EZH2 and PI3K\/AKT pathway. J. Cell. Mol. Med. 27, 3526\u20133538 (2023).","journal-title":"J. Cell. Mol. Med."},{"key":"16789_CR16","doi-asserted-by":"crossref","unstructured":"Wang, Y., Lin, C. & Exosomes miR-22-3p derived from mesenchymal stem cells suppress colorectal cancer cell proliferation and invasion by regulating RAP2B and PI3K\/AKT pathway. J. Oncol. 2021, 3874478 (2021).","DOI":"10.1155\/2021\/3874478"},{"key":"16789_CR17","first-page":"177","volume":"19","author":"S Wu","year":"2019","unstructured":"Wu, S. et al. Human adipose\u2013derived mesenchymal stem cells promote breast cancer MCF7 cell epithelial\u2013mesenchymal transition by cross interacting with the TGF\u2013\u03b2\/Smad and PI3K\/AKT signaling pathways. Mol. Med. Rep. 19, 177\u2013186 (2019).","journal-title":"Mol. Med. Rep."},{"key":"16789_CR18","first-page":"75","volume":"7","author":"WS Khan","year":"2012","unstructured":"Khan, W. S. & Hardingham, T. E. Mesenchymal stem cells, sources of cells and differentiation potential. J. Stem Cells. 7, 75 (2012).","journal-title":"J. Stem Cells"},{"key":"16789_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4252\/wjsc.v2.i4.81","volume":"2","author":"K Bieback","year":"2010","unstructured":"Bieback, K. & Brinkmann, I. Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J. Stem Cells. 2, 81\u201392 (2010).","journal-title":"World J. Stem Cells"},{"key":"16789_CR20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/jso.24759","volume":"116","author":"S Buettner","year":"2017","unstructured":"Buettner, S. et al. Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. J. Surg. Oncol. 116, 1085\u20131095 (2017).","journal-title":"J. Surg. Oncol."},{"key":"16789_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fgene.2013.00261","volume":"4","author":"H Yagi","year":"2013","unstructured":"Yagi, H. & Kitagawa, Y. The role of mesenchymal stem cells in cancer development. Front. Genet. 4, 261 (2013).","journal-title":"Front. Genet."},{"key":"16789_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","volume":"28","author":"RJ Deans","year":"2000","unstructured":"Deans, R. J. & Moseley, A. B. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28, 875\u2013884 (2000).","journal-title":"Exp. Hematol."},{"key":"16789_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt131","volume":"3","author":"K Akiyama","year":"2012","unstructured":"Akiyama, K. et al. Characterization of bone marrow derived mesenchymal stem cells in suspension. Stem Cell. Res. Ther. 3, 1\u201313 (2012).","journal-title":"Stem Cell. Res. Ther."},{"key":"16789_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/14653240600621125","volume":"8","author":"M Oedayrajsingh-Varma","year":"2006","unstructured":"Oedayrajsingh-Varma, M. et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8, 166\u2013177 (2006).","journal-title":"Cytotherapy"},{"key":"16789_CR25","first-page":"461","volume":"13","author":"S Dabiri","year":"2018","unstructured":"Dabiri, S., Derakhshani, A., Vahidi, R. & Farsinejad, A. Peripheral blood-derived mesenchymal stem cells: growth factor-free isolation, molecular characterization and differentiation. Iran. J. Pathol. 13, 461\u2013466 (2018).","journal-title":"Iran. J. Pathol."},{"key":"16789_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jcyt.2017.03.001","volume":"19","author":"AB Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo, A. B. et al. Comparison of human mesenchymal stromal cells from four neonatal tissues: amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy 19, 577\u2013585 (2017).","journal-title":"Cytotherapy"},{"key":"16789_CR27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/ijms21030708","volume":"21","author":"DT Chu","year":"2020","unstructured":"Chu, D. T. et al. An update on the progress of isolation, culture, storage, and clinical application of human bone marrow mesenchymal stem\/stromal cells. Int. J. Mol. Sci. 21, 708 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"16789_CR28","doi-asserted-by":"crossref","unstructured":"Aithal, A. P., Bairy, L. K. & Seetharam, R. N. Safety and therapeutic potential of human bone marrow-derived mesenchymal stromal cells in regenerative medicine. Stem Cell. Investig. 8 (2021).","DOI":"10.21037\/sci-2020-036"},{"key":"16789_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","volume":"33","author":"K Stenderup","year":"2003","unstructured":"Stenderup, K., Justesen, J., Clausen, C. & Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 33, 919\u2013926 (2003).","journal-title":"Bone"},{"key":"16789_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bone.2014.10.014","volume":"70","author":"N Baker","year":"2015","unstructured":"Baker, N., Boyette, L. B. & Tuan, R. S. Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone. 70, 37\u201347 (2015).","journal-title":"Bone"},{"key":"16789_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4252\/wjsc.v4.i6.53","volume":"4","author":"S Vellasamy","year":"2012","unstructured":"Vellasamy, S., Sandrasaigaran, P., Vidyadaran, S., George, E. & Ramasamy, R. Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. World J. Stem Cells. 4, 53\u201361 (2012).","journal-title":"World J. Stem Cells"},{"key":"16789_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass, R., Kasper, C., B\u00f6hm, S. & Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell. Commun. Signal. 9, 1\u201314 (2011).","journal-title":"Cell. Commun. Signal."},{"key":"16789_CR33","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/ijms20071656","volume":"20","author":"G Sagaradze","year":"2019","unstructured":"Sagaradze, G. et al. Conditioned medium from human mesenchymal stromal cells: towards the clinical translation. Int. J. Mol. Sci. 20, 1656 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"16789_CR34","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.3390\/ijms241713511","volume":"24","author":"Y Slama","year":"2023","unstructured":"Slama, Y. et al. The dual role of mesenchymal stem cells in cancer pathophysiology: pro-tumorigenic effects versus therapeutic potential. Int. J. Mol. Sci. 24, 13511 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"16789_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/term.2806","volume":"13","author":"TNA Gunawardena","year":"2019","unstructured":"Gunawardena, T. N. A., Rahman, M. T. & Abdullah, B. J. J. Abu kasim, N. H. Conditioned media derived from mesenchymal stem cell cultures: the next generation for regenerative medicine. J. Tissue Eng. Regen. Med. 13, 569\u2013586 (2019).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"16789_CR36","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3892\/ol.2017.5641","volume":"13","author":"P Li","year":"2017","unstructured":"Li, P. et al. Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation. Oncol. Lett. 13, 1581\u20131586 (2017).","journal-title":"Oncol. Lett."},{"key":"16789_CR37","first-page":"339","volume":"41","author":"RM Folcuti","year":"2015","unstructured":"Folcuti, R. M. et al. The effect of human mesenchymal stem cells-conditioned media on glioblastoma cells viability in vitro. Curr. Health Sci. J. 41, 339\u2013344 (2015).","journal-title":"Curr. Health Sci. J."},{"key":"16789_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3892\/ol.2015.3360","volume":"10","author":"JH Lee","year":"2015","unstructured":"Lee, J. H., Park, C. H., Chun, K. H. & Hong, S. S. Effect of adipose-derived stem cell-conditioned medium on the proliferation and migration of B16 melanoma cells. Oncol. Lett. 10, 730\u2013736 (2015).","journal-title":"Oncol. Lett."},{"key":"16789_CR39","doi-asserted-by":"publisher","first-page":"11341","DOI":"10.1038\/s41598-022-15298-0","volume":"12","author":"T Jantalika","year":"2022","unstructured":"Jantalika, T. et al. Human chorion-derived mesenchymal stem cells suppress JAK2\/STAT3 signaling and induce apoptosis of cholangiocarcinoma cell lines. Sci. Rep. 12, 11341 (2022).","journal-title":"Sci. Rep."},{"key":"16789_CR40","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3390\/cells12242788","volume":"12","author":"T Jantalika","year":"2023","unstructured":"Jantalika, T. et al. The human placental amniotic membrane mesenchymal-stromal-cell-derived conditioned medium inhibits growth and promotes apoptosis of human cholangiocarcinoma cells in vitro and in vivo by suppressing IL-6\/JAK2\/STAT3 signaling. Cells. 12, 2788 (2023).","journal-title":"Cells"},{"key":"16789_CR41","first-page":"8536","volume":"15","author":"Y Yuan","year":"2018","unstructured":"Yuan, Y. et al. Suppression of tumor cell proliferation and migration by human umbilical cord mesenchymal stem cells: A possible role for apoptosis and Wnt signaling. Oncol. Lett. 15, 8536\u20138544 (2018).","journal-title":"Oncol. Lett."},{"key":"16789_CR42","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/cas.13479","volume":"109","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3\u2010kinase\/Akt\/mammalian target of Rapamycin. Cancer Sci. 109, 688\u2013698 (2018).","journal-title":"Cancer Sci."},{"key":"16789_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/gutjnl-2011-301393","volume":"62","author":"A De Boeck","year":"2013","unstructured":"De Boeck, A. et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1\/HER3 signalling. Gut 62, 550\u2013560 (2013).","journal-title":"Gut"},{"key":"16789_CR44","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.humpath.2012.07.004","volume":"43","author":"HS Ryu","year":"2012","unstructured":"Ryu, H. S. et al. Overexpression of epithelial-mesenchymal transition\u2013related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma. Hum. Pathol. 43, 2360\u20132370 (2012).","journal-title":"Hum. Pathol."},{"key":"16789_CR45","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1084\/jem.20181827","volume":"216","author":"NM Aiello","year":"2019","unstructured":"Aiello, N. M. & Kang, Y. Context-dependent EMT programs in cancer metastasis. J. Exp. Med. 216, 1016\u20131026 (2019).","journal-title":"J. Exp. Med."},{"key":"16789_CR46","doi-asserted-by":"crossref","unstructured":"Savagner, P., Gilles, C., Newgreen, D. F., Sato, H. & Thompson, E. W. Springer,. Matrix metalloproteases and epithelial-to-mesenchymal transition: implications for carcinoma metastasis. Rise and fall of epithelial phenotype: concepts of epithelial-mesenchymal transition (ed. Savagner, P.) 297\u2013315 (2005).","DOI":"10.1007\/0-387-28671-3_20"},{"key":"16789_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-022-02676-x","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard, S. et al. Role of PI3K\/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers. Cancer Cell. Int. 22, 1\u201327 (2022).","journal-title":"Cancer Cell. Int."},{"key":"16789_CR48","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/ph5111236","volume":"5","author":"EG Sarris","year":"2012","unstructured":"Sarris, E. G., Saif, M. W. & Syrigos, K. N. The biological role of PI3K pathway in lung cancer. Pharmaceuticals 5, 1236\u20131264 (2012).","journal-title":"Pharmaceuticals"},{"key":"16789_CR49","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh, M. D. A. et al. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol. Res. 187, 106553 (2023).","journal-title":"Pharmacol. Res."},{"key":"16789_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ctrv.2018.11.001","volume":"72","author":"F Corti","year":"2019","unstructured":"Corti, F. et al. Targeting the PI3K\/AKT\/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treat. Rev. 72, 45\u201355 (2019).","journal-title":"Cancer Treat. Rev."},{"key":"16789_CR51","doi-asserted-by":"publisher","first-page":"108625","DOI":"10.1016\/j.biopha.2019.108625","volume":"112","author":"L Lu","year":"2019","unstructured":"Lu, L. et al. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K\/AKT signaling pathway. Biomed. Pharmacother. 112, 108625 (2019).","journal-title":"Biomed. Pharmacother"},{"key":"16789_CR52","doi-asserted-by":"publisher","first-page":"e62844","DOI":"10.1371\/journal.pone.0062844","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu, J., Han, G., Liu, H. & Qin, C. Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling. PLoS One. 8, e62844 (2013).","journal-title":"PLoS One"},{"key":"16789_CR53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.7150\/jca.77905","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Inhibition of STAT3 signaling as critical molecular event in HUC-MSCs suppressed glioblastoma cells. J. Cancer. 14, 611\u2013627 (2023).","journal-title":"J. Cancer"},{"key":"16789_CR54","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3892\/or.2016.4853","volume":"36","author":"M Li","year":"2016","unstructured":"Li, M. et al. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1\/Wnt\/\u03b2-catenin signaling pathway. Oncol. Rep. 36, 936\u2013944 (2016).","journal-title":"Oncol. Rep."},{"key":"16789_CR55","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s13277-013-0930-9","volume":"34","author":"H Dokduang","year":"2013","unstructured":"Dokduang, H. et al. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. Tumor Biol. 34, 3519\u20133528 (2013).","journal-title":"Tumor Biol."},{"key":"16789_CR56","doi-asserted-by":"publisher","first-page":"741","DOI":"10.31557\/APJCP.2023.24.3.741","volume":"24","author":"R Idris","year":"2023","unstructured":"Idris, R., Chaijaroenkul, W. & Na-Bangchang, K. Molecular targets and signaling pathways in cholangiocarcinoma: A systematic review. Asian Pac. J. Cancer Prev. 24, 741\u2013751 (2023).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"16789_CR57","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/mt.2015.13","volume":"23","author":"Y Yulyana","year":"2015","unstructured":"Yulyana, Y. et al. Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R\/PI3K\/Akt signaling. Mol. Ther. 23, 746\u2013756 (2015).","journal-title":"Mol. Ther."},{"key":"16789_CR58","doi-asserted-by":"crossref","unstructured":"Wang, Y. & Lin, C. Exosomes miR-22\u20103p derived from mesenchymal stem cells suppress colorectal cancer cell proliferation and invasion by regulating RAP2B and PI3K\/AKT pathway. J. Oncol. 2021, 3874478 (2021).","DOI":"10.1155\/2021\/3874478"},{"key":"16789_CR59","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s10620-020-06458-1","volume":"66","author":"T Li","year":"2021","unstructured":"Li, T. et al. Mesenchymal stem cell-derived exosomal microRNA-3940-5p inhibits colorectal cancer metastasis by targeting integrin \u03b16. Dig. Dis. Sci. 66, 1916\u20131927 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"16789_CR60","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.21037\/tcr-20-83","volume":"9","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Mesenchymal stem cell-derived exosomes carrying microRNA-150 suppresses the proliferation and migration of osteosarcoma cells via targeting IGF2BP1. Transl. Cancer Res. 9, 5323\u20135335 (2020).","journal-title":"Transl. Cancer Res."},{"key":"16789_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13287-019-1446-z","volume":"10","author":"H Xu","year":"2019","unstructured":"Xu, H. et al. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt\/\u03b2-catenin signaling pathway by targeting EZH2. Stem Cell. Res. Ther. 10, 381 (2019).","journal-title":"Stem Cell. Res. Ther."},{"key":"16789_CR62","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2018.10.017","volume":"440","author":"PY Jung","year":"2019","unstructured":"Jung, P. Y. et al. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-\u03b2 and TRAIL and suppress the growth of H460 human lung cancer cells. Cancer Lett. 440, 202\u2013210 (2019).","journal-title":"Cancer Lett."},{"key":"16789_CR63","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7150\/ijms.41354","volume":"17","author":"CS Byun","year":"2020","unstructured":"Byun, C. S. et al. Adipose tissue-derived mesenchymal stem cells suppress growth of Huh7 hepatocellular carcinoma cells via interferon (IFN)-\u03b2-mediated JAK\/STAT1 pathway in vitro. Int. J. Med. Sci. 17, 609\u2013619 (2020).","journal-title":"Int. J. Med. Sci."},{"key":"16789_CR64","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/mc.22178","volume":"54","author":"MR Clarke","year":"2015","unstructured":"Clarke, M. R., Imhoff, F. M. & Baird, S. K. Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and\u20102. Mol. Carcinog. 54, 1214\u20131219 (2015).","journal-title":"Mol. Carcinog."},{"key":"16789_CR65","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3748\/wjg.v11.i22.3392","volume":"11","author":"B Sripa","year":"2005","unstructured":"Sripa, B. et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J. Gastroenterol. 11, 3392\u20133397 (2005).","journal-title":"World J. Gastroenterol."},{"key":"16789_CR66","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s13577-020-00334-w","volume":"33","author":"B Sripa","year":"2020","unstructured":"Sripa, B. et al. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Hum. Cell. 33, 695\u2013708 (2020).","journal-title":"Hum. Cell."},{"key":"16789_CR67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"}],"updated-by":[{"DOI":"10.1038\/s41598-026-67134-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16789-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16789-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16789-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:04:15Z","timestamp":1788354255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16789-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16789-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-67134-4","URL":"https:\/\/doi.org\/10.1038\/s41598-026-67134-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31472"}}